Fed. Circ. Upholds Preliminary Ban on Roche's Mircera
An appeals court on Friday dashed Roche Holding AG's hopes of bringing its generic anemia drug Mircera to market in the U.S. any time soon, affirming a lower court's decision to...To view the full article, register now.
Already a subscriber? Click here to view full article